Trial Profile
The effects of olmesartan medoxomil on pulse wave velocity and oxidative stress in type2 diabetes mellitus-pulse wave velocity (baPWV, CAVI) subanalysis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Jan 2020
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 24 Jan 2020 Status changed from recruiting to completed.
- 21 Jul 2011 New trial record